Who owns Sana Biotechnology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SANA from SEC Form 13F filings across 212 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 212 institutions disclosed 184.8M shares of Sana Biotechnology, Inc. worth $644.7M — about 62.5% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
212
13F holders
$644.7M
value, 2026 filers
62.5%
of shares outstanding (184.8M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of SANA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 37.4M | $130.6M | 0.0% | 12.7% | 0.0% |
| 2 | Flagship Pioneering, LLC | 25.0M | $87.3M | 5.7% | 8.5% | 0.0% |
| 3 | RA CAPITAL MANAGEMENT, L.P.NEW | 18.8M | $65.4M | 0.6% | 6.3% | new |
| 4 | BlackRock, Inc. | 16.7M | $58.2M | 0.0% | 5.6% | +17.1% |
| 5 | STATE STREET CORP | 11.2M | $39.1M | 0.0% | 3.8% | +6.3% |
| 6 | CANADA PENSION PLAN INVESTMENT BOARD | 10.2M | $35.7M | 0.0% | 3.5% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 8.4M | $29.2M | 0.0% | 2.8% | +12.7% |
| 8 | BANK OF AMERICA CORP /DE/ | 5.7M | $20.1M | 0.0% | 1.9% | +95.1% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 4.7M | $16.3M | 0.0% | 1.6% | +11.9% |
| 10 | Marex Group Ltd | 4.0M | $13.9M | 0.1% | 1.3% | -0.3% |
| 11 | MARSHALL WACE, LLP | 2.9M | $10.2M | 0.0% | 1% | +341.2% |
| 12 | Alphabet Inc. | 2.8M | $9.8M | 0.0% | 1% | 0.0% |
| 13 | GOLDMAN SACHS GROUP INC | 2.4M | $8.3M | 0.0% | 0.8% | -25.6% |
| 14 | Integral Health Asset Management, LLC | 2.0M | $7.0M | 0.3% | 0.7% | -37.5% |
| 15 | TORONTO DOMINION BANKNEW | 2.0M | $6.9M | 0.0% | 0.7% | new |
| 16 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9M | $6.6M | 0.0% | 0.6% | +10.2% |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INCNEW | 1.9M | $6.5M | 0.0% | 0.6% | new |
| 18 | NORTHERN TRUST CORP | 1.6M | $5.6M | 0.0% | 0.5% | +8.5% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4M | $4.8M | 0.0% | 0.5% | +1.0% |
| 20 | Woodline Partners LP | 1.3M | $4.6M | 0.0% | 0.4% | 0.0% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $4.3M | 0.0% | 0.4% | +16.3% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 1.2M | $4.3M | 0.0% | 0.4% | -15.2% |
| 23 | MORGAN STANLEY | 1.1M | $4.0M | 0.0% | 0.4% | -21.9% |
| 24 | UBS Group AG | 1.1M | $3.7M | 0.0% | 0.4% | -21.7% |
| 25 | AQR CAPITAL MANAGEMENT LLC | 963,147 | $3.4M | 0.0% | 0.3% | -14.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.